$215 Million is the total value of Eversept Partners, LP's 57 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 71.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QCP | Buy | QUALITY CARE PPTYS INC | $20,025,743 | +483.2% | 1,030,661 | +314.5% | 9.30% | +370.7% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $15,789,000 | -34.3% | 60,000 | -33.3% | 7.33% | -46.9% |
| RCM | Buy | R1 RCM INC | $13,636,593 | +88.3% | 1,909,887 | +16.3% | 6.33% | +52.0% |
| RDUS | Buy | RADIUS HEALTH INC | $11,994,544 | +94.1% | 333,738 | +71.6% | 5.57% | +56.7% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $11,434,707 | -20.7% | 210,778 | -12.7% | 5.31% | -36.0% |
| ABLX | Buy | ABLYNX NVsponsored adr | $9,923,973 | +293.7% | 181,891 | +80.3% | 4.61% | +217.6% |
| AVXS | Buy | AVEXIS INC | $9,664,080 | +219.0% | 78,201 | +185.7% | 4.49% | +157.5% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $9,396,156 | – | 78,893 | +100.0% | 4.36% | – |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $8,948,163 | – | 226,584 | +100.0% | 4.16% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $8,721,126 | – | 220,788 | +100.0% | 4.05% | – |
| ENSG | Sell | ENSIGN GROUP INC | $8,585,124 | +16.3% | 325,897 | -1.8% | 3.99% | -6.1% |
| ZGNX | Sell | ZOGENIX INC | $8,192,067 | -6.3% | 204,546 | -6.3% | 3.80% | -24.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $7,305,090 | -16.1% | 44,822 | -22.9% | 3.39% | -32.3% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $5,838,105 | -63.2% | 357,727 | -71.1% | 2.71% | -70.3% |
| SNY | Sell | SANOFIsponsored adr | $5,529,918 | -31.6% | 137,972 | -26.6% | 2.57% | -44.8% |
| NVRO | Sell | NEVRO CORP | $5,273,870 | +17.8% | 60,850 | -6.2% | 2.45% | -4.9% |
| TLGT | Sell | TELIGENT INC NEW | $5,209,287 | -13.6% | 1,550,383 | -6.7% | 2.42% | -30.3% |
| SAGE | New | SAGE THERAPEUTICS INC | $3,865,680 | – | 24,000 | +100.0% | 1.80% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $3,729,220 | -8.5% | 46,000 | +0.7% | 1.73% | -26.1% |
| TSRO | Sell | TESARO INC | $2,944,024 | -58.6% | 51,523 | -39.9% | 1.37% | -66.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $2,878,465 | +64.8% | 35,784 | +29.4% | 1.34% | +33.0% |
| ABT | New | ABBOTT LABS | $2,870,168 | – | 47,900 | +100.0% | 1.33% | – |
| TGTX | New | TG THERAPEUTICS INC | $2,130,000 | – | 150,000 | +100.0% | 0.99% | – |
| ABMD | Sell | ABIOMED INC | $2,064,283 | +28.2% | 7,094 | -17.5% | 0.96% | +3.5% |
| MYOK | Sell | MYOKARDIA INC | $2,049,600 | -2.6% | 42,000 | -16.0% | 0.95% | -21.4% |
| IVC | Buy | INVACARE CORP | $1,738,295 | +6.0% | 99,902 | +2.7% | 0.81% | -14.4% |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,705,204 | – | 85,090 | +100.0% | 0.79% | – |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $1,573,132 | +224.1% | 24,054 | +98.5% | 0.73% | +162.0% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $1,559,978 | -71.1% | 22,924 | -58.1% | 0.72% | -76.7% |
| CTRE | Sell | CARETRUST REIT INC | $1,472,932 | -37.1% | 108,264 | -21.7% | 0.68% | -49.3% |
| ANTM | New | ANTHEM INC | $1,318,200 | – | 6,000 | +100.0% | 0.61% | – |
| MDCO | New | MEDICINES CO | $1,295,102 | – | 39,317 | +100.0% | 0.60% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $1,098,500 | – | 65,000 | +100.0% | 0.51% | – |
| HAE | New | HAEMONETICS CORP | $1,071,501 | – | 14,646 | +100.0% | 0.50% | – |
| CNC | New | CENTENE CORP DEL | $1,068,700 | – | 10,000 | +100.0% | 0.50% | – |
| EHTH | Sell | EHEALTH INC | $1,066,753 | -81.3% | 74,546 | -77.3% | 0.50% | -84.9% |
| EPZM | New | EPIZYME INC | $1,019,720 | – | 57,449 | +100.0% | 0.47% | – |
| MGLN | MAGELLAN HEALTH INC | $994,102 | +10.9% | 9,282 | 0.0% | 0.46% | -10.5% | |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $859,740 | -43.7% | 17,800 | -54.1% | 0.40% | -54.6% |
| ARNA | New | ARENA PHARMACEUTICALS INCcall | $825,550 | – | 20,900 | +100.0% | 0.38% | – |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $753,390 | -15.2% | 3,000 | -25.0% | 0.35% | -31.5% |
| AMRN | New | AMARIN CORP PLCspons adr new | $752,500 | – | 250,000 | +100.0% | 0.35% | – |
| IRMD | IRADIMED CORP | $735,250 | -5.0% | 51,059 | 0.0% | 0.34% | -23.4% | |
| AFMD | New | AFFIMED N V | $715,695 | – | 386,862 | +100.0% | 0.33% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $710,534 | -27.0% | 148,959 | -24.9% | 0.33% | -41.1% |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $595,500 | – | 30,000 | +100.0% | 0.28% | – |
| ABUS | Buy | ARBUTUS BIOPHARMA CORP | $587,475 | +8.2% | 117,495 | +9.3% | 0.27% | -12.5% |
| ALBO | New | ALBIREO PHARMA INC | $587,205 | – | 18,029 | +100.0% | 0.27% | – |
| MLNT | New | MELINTA THERAPEUTICS INC | $568,594 | – | 76,837 | +100.0% | 0.26% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $551,475 | – | 107,500 | +100.0% | 0.26% | – |
| AQXP | Buy | AQUINOX PHARMACEUTICALS INC | $450,377 | +91.5% | 31,987 | +59.9% | 0.21% | +54.8% |
| OPHT | OPHTHOTECH CORP | $408,534 | -12.2% | 149,100 | 0.0% | 0.19% | -29.1% | |
| EVHC | Sell | ENVISION HEALTHCARE CORP | $365,854 | -86.7% | 9,520 | -88.0% | 0.17% | -89.2% |
| MDXG | New | MIMEDX GROUP INCcall | $334,560 | – | 48,000 | +100.0% | 0.16% | – |
| SPNE | SEASPINE HLDGS CORP | $313,316 | +0.2% | 30,899 | 0.0% | 0.15% | -18.9% | |
| DERM | New | DERMIRA INC | $159,944 | – | 20,018 | +100.0% | 0.07% | – |
| QTNT | QUOTIENT LTD | $49,507 | -4.8% | 10,511 | 0.0% | 0.02% | -23.3% | |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -66,980 | -100.0% | -0.14% | – |
| IVTY | Exit | INVUITY INC | $0 | – | -45,000 | -100.0% | -0.16% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.20% | – |
| ARDMQ | Exit | ARADIGM CORP | $0 | – | -52,115 | -100.0% | -0.20% | – |
| CIVI | Exit | CIVITAS SOLUTIONS INC | $0 | – | -23,529 | -100.0% | -0.23% | – |
| VREX | Exit | VAREX IMAGING CORP | $0 | – | -20,700 | -100.0% | -0.48% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -16,397 | -100.0% | -0.64% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -25,100 | -100.0% | -0.66% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -57,723 | -100.0% | -0.94% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -14,000 | -100.0% | -0.97% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -33,500 | -100.0% | -2.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.